MOXIFLOXACIN HYDROC
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc. a contract valued at $862.50 under the delivery order SPE2DX25D9900, with the award issued on July 30, 2026. The contract is for the procurement of Moxifloxacin Hydrochloride, identified by NSN 6505015163194 and PR 7017693375, intended for federal use. The awardee, identified by CAGE code 1UNB0, is a supplier contracted through the Department of Defense's procurement system. This transaction is classified as a federal award with no set-aside designation, and the performance location is not specified beyond the United States. The official record can be accessed through the DIBBS portal using the provided UI link, and the solicitation number associated with this award is SPE2DP26F8466.
General Info
Agency
Contract Value
$862.5NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
